Remote monitoring may Fine-Tune heart failure meds faster
NCT ID NCT07518030
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether telemedicine follow-up helps doctors adjust heart failure medications more effectively than standard in-person visits. Eighty adults with newly diagnosed heart failure with reduced ejection fraction will be randomly assigned to either remote monitoring or usual care. The main goal is to see if the telemedicine group achieves better medication optimization after six months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
telemedicine-based follow-up
What this could lead to
If successful, this could show that remote monitoring and virtual check-ins help doctors fine-tune heart failure medications more quickly and safely than standard in-person visits.
What could go wrong
This is a small, early-stage trial with only 80 participants, so results may not apply to everyone. Telemedicine may not work as well for patients with limited digital skills or access.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Research Office, AUSL Piacenza
RECRUITINGPiacenza, 29121, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••